Hybridization linkers
US-9222082-B2 · Dec 29, 2015 · US
US8993302B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8993302-B2 |
| Application number | US-201013266466-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 23, 2010 |
| Priority date | Apr 29, 2009 |
| Publication date | Mar 31, 2015 |
| Grant date | Mar 31, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a mutant Francisella tularensis strain comprising an inactivated clpB gene and compositions comprising such mutant. Methods of producing the mutant are also described. The present invention also encompasses a method of conferring immunity against F. tularensis in a host, comprising administering the described mutant F. tularensis strain.
Opening claim text (preview).
The invention claimed is: 1. An attenuated Francisella tularensis mutant strain wherein the caseinolytic peptidase B (c/pB) gene is deleted, wherein the mutant is a variant of the wild-type clinical strain of F. tularensis selected from the group consisting of SCHU S4, FS033, FSC 108 and FSC 200. 2. The mutant F. tularensis strain of claim 1 , wherein the mutant is more attenuated than F. tularensis LVS. 3. The mutant F. tularensis…
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.